2024-513918-35-00招募中1 期
Study of JNJ-74856665 in patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome
Janssen Cilag International, Janssen Cilag International1 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2024年7月26日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 1
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
CTIS Point of Contact
Scientific
Janssen Cilag International
研究点 (1)
Loading locations...
相似试验
招募中
2 期
AML-NET : Acute Myeloid Leukemia treated with with NETrin Abs in combination with [AZACITIDINE + VENETOCLAX]Refractory Acute Myeloïd Leukemia2023-503408-10-00Centre Leon Berard, Centre Leon Berard35
招募中
1 期
A Phase 1 Study of JNJ-87562761 in Relapsed/Refractory Multiple MyelomaRelapsed/Refractory Multiple Myeloma2024-513439-25-00Janssen Cilag International15
招募中
2 期
A Clinical study of MK-4716 in people with certain solid tumors (MK-4716-001)Cancer – Solid Tumors : 1L NSCLC and all other advanced or metastatic solid tumors with KRAS alterations (KRAS mutation or KRAS amplification)2025-522495-84-00Merck Sharp & Dohme LLC29
招募中
1 期
A Phase 1, First-in-human Study of JNJ-80948543, a T-cell Redirecting Antibody, in Participants with NHL and CLLNon-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)2023-504187-42-00Janssen - Cilag International52
招募中
1 期
A Phase 1 Study of JNJ-87801493 in Combination with CD3 T-Cell EngagersNon-Hodgkin Lymphoid Malignancies2023-505165-93-00Janssen - Cilag International70